Algo version: 0.98b
Aurobindo Pharma Limited is listed at the NSE Exchange
Aurobindo Pharma Limited [AUROPHARMA.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Aurobindo Pharma Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Aurobindo Pharma Limited pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 20th of February 2024 were paid INR1.5 per share. Over the last 44 times between 2001 and 2024, Aurobindo Pharma Limited has paid INR86.5 with an average of INR1.97 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Aurobindo Pharma Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR625.75, you would have made a profit of INR911.65 per share or 145.69%

Yes, the average daily trading liquidity for Aurobindo Pharma Limited is INR1.52 million. You should therefore be able to get in and out of your positions relatively fast.

Aurobindo Pharma Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.47, the company's ability to pay off the debt is normal. Aurobindo Pharma Limited has a good net profit margin of 11.02% and should have high tolerances against inflation.

We have calculated the inflation risk for Aurobindo Pharma Limited to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.